…stranded RNA sensor Retinoic Acid Inducible Gene I (RIG-I), and CAR-T cell therapy using syngeneic and human xenograft PDAC models. Tumor growth, …
chimeric antigen receptor (CAR)-T cell therapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning chimeric antigen receptor (CAR)-T cell therapy
7 articles · page 1 of 1…Background Chimeric antigen receptor (CAR)-T cell therapy has been successful for the treatment of hematological cancers …
…Background While chimeric antigen receptor (CAR)-T cell therapy has transformed the treatment landscape for certain hematologic…
…Background Chimeric antigen receptor (CAR)-T cell therapy has achieved significant success in hematologic malignancies; h…
…Background Chimeric antigen receptor (CAR)-T cell therapy has demonstrated remarkable success in hematologic malignancies…
…Background Chimeric antigen receptor (CAR)-T cell therapy represents an innovative and potentially revolutionary modality…
…eterogeneity and antigen escape are mechanisms of resistance to chimeric antigen receptor (CAR)-T cell therapy, especially in solid tumors. Targeting multiple antigens with a…